Showing results (281-290 of 322) with videos related to

Sort By:
Pageof 33
Journal of Medicinal Chemistry|December 2, 2015
4-Phenylpyridin-2-one Derivatives: A Novel Class of Positive Allosteric Modulator of the M1 Muscarinic Acetylcholine ReceptorShailesh N Mistry, Manuela Jörg, Herman Lim, et al.
Plos One|September 11, 2024
The chemokine receptor CCR8 is not a high-affinity receptor for the human chemokine CCL18Khansa Hussain, Herman D Lim, Shankar Raj Devkota, et al.
The Journal of Biological Chemistry|January 21, 2014
Molecular determinants of allosteric modulation at the M1 muscarinic acetylcholine receptorAlaa Abdul-Ridha, Laura López, Peter Keov, et al.
Journal of Medicinal Chemistry|April 24, 2018
A Thieno[2,3- d]pyrimidine Scaffold Is a Novel Negative Allosteric Modulator of the Dopamine D2 ReceptorTim J Fyfe, Barbara Zarzycka, Herman D Lim, et al.
Journal of the American Chemical Society|February 9, 2018
Selective Photoaffinity Probe That Enables Assessment of Cannabinoid CB2 Receptor Expression and Ligand Engagement in Human CellsMarjolein Soethoudt, Sara C Stolze, Matthias V Westphal, et al.
British Journal of Pharmacology|July 25, 2023
Assessment of the potential of novel and classical opioids to induce respiratory depression in miceRob Hill, Julie Sanchez, Laura Lemel, et al.
Journal of Medicinal Chemistry|July 19, 2023
Pharmacological and Physicochemical Properties Optimization for Dual-Target Dopamine D3 (D3R) and μ-Opioid (MOR) Receptor Ligands as Potentially Safer AnalgesicsAlessandro Bonifazi, Elizabeth Saab, Julie Sanchez, et al.
Journal of Medicinal Chemistry|August 11, 2015
Discovery of a Novel Class of Negative Allosteric Modulator of the Dopamine D2 Receptor Through Fragmentation of a Bitopic LigandShailesh N Mistry, Jeremy Shonberg, Christopher J Draper-Joyce, et al.
Biological Psychiatry|July 9, 2025
Mu Opioid Receptor Activation is Required for NMDA Receptor Antagonist Effects on Stress-induced Maladaptive BehaviorCory B Langreck, Briana Chen, Victor M Luna, et al.
ACS Chemical Neuroscience|September 24, 2020
Evidence for a Stereoselective Mechanism for Bitopic Activity by Extended-Length Antagonists of the D3 Dopamine ReceptorAmy E Moritz, Alessandro Bonifazi, Adrian M Guerrero, et al.
Pageof 33